BioBridge Global-Led Biotech Team Awarded $7.8 million Army Contract: Funds Will Help Develop Capability for Large-Scale Manufacturing of Stem Cells

BioBridge Global-Led Biotech Team Awarded $7.8 million Army Contract: Funds Will Help Develop Capability for Large-Scale Manufacturing of Stem Cells

A biotech group led by BioBridge Global has been awarded a $7.8 million contract from the Medical Technology Enterprise Consortium for the development of large-scale manufacturing capabilities for clinical-grade stem cells for research and therapeutic use.

San Antonio, Texas

A four-organization biotech group led by San Antonio-based nonprofit BioBridge Global (BBG) has been awarded a $7.8 million contract from the Medical Technology Enterprise Consortium (MTEC). The funds will enable the development of large-scale manufacturing capabilities for clinical-grade stem cells for research and therapeutic use.

BBG led a group including the U.S. Army Institute of Surgical Research (USAISR) Coagulation and Blood Research, San Antonio biotech firm StemBioSys and Maryland-based RoosterBio Inc. in submitting the proposal for funding.

< | >